Targeting hepcidin to restore oral iron efficacy after vertical sleeve gastrectomy
Frontiers in Nutrition · 01.06.2026 · 13
DOI: 10.3389/fnut.2026.1746572 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 01.06.2026. Verfasst von Xiaozhuo Tan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Obesity and Hernia Surgery, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Metabolic bariatric surgery (MBS) such as Vertical Sleeve Gastrectomy (VSG) is the most effective intervention for obesity but commonly results in iron deficiency, inadequately managed by oral iron supplementation. This study aimed to investigate mechanisms underlying the inefficacy of oral iron supplementation post-VSG, evaluate clinical relevance through patient studies, and test the therapeutic potential of curcumin, a hepcidin inhibitor, to improve iron management.
Methods
Diet-induced obese mice underwent VSG or sham surgery and received either regular-iron or iron-rich diets postoperatively, with or without curcumin supplementation. Systemic and tissue iron metrics, expressions of genes and proteins involved in iron metabolism were analyzed. Clinically, we evaluated circulating hepcidin levels in VSG patients developing iron deficiency vs. matched controls without deficiency at 6-months post-surgery.
Results
In mouse models, VSG induced persistent iron deficiency that could not be corrected by oral iron supplementation. VSG increased intestinal dietary iron uptake capacity, yet oral iron triggered a disproportionate rise in hepatic hepcidin. The resulting hepcidin-mediated ferroportin loss traped absorbed iron within enterocytes, hepatocytes, and macrophages, producing persistent systemic iron deficiency despite supplementation. Moreover, curcumin, a hepcidin-suppressive intervention, restored ferroportin protein, mobilized sequestered iron, and rescued serum iron indices while leaving the VSG-induced intestinal iron absorption machinery intact. In patients 6 months after VSG receiving routine oral iron supplementation, those with iron deficiency exhibit higher hepcidin than matched non-deficient controls, and hepcidin levels were inversely correlated with circulating iron levels.
Conclusions
These results reframe post-VSG iron deficiency as a disorder of iron mobilization and regulation, not merely reduced absorption. Clinically, they argue for therapeutic strategies that target the hepcidin-ferroportin axis to restore the efficacy of oral iron supplementation in correcting iron deficiency following MBS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Obesity and Hernia Surgery, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.
- Department of Surgery, University of Michigan, Ann Arbor, MI, United States.
Zitieren
APA
Tan, X., Cao, C., Huang, X., Hua, R., Seeley, R. J., Yao, Q., Xu, B., & Shao, Y. (2026). Targeting hepcidin to restore oral iron efficacy after vertical sleeve gastrectomy. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1746572
Vancouver
Tan X, Cao C, Huang X, Hua R, Seeley RJ, Yao Q, et al. Targeting hepcidin to restore oral iron efficacy after vertical sleeve gastrectomy. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1746572
BibTeX
@article{Tan2026,
author = {Tan, Xiaozhuo and Cao, Chong and Huang, Xianjue and Hua, Rong and Seeley, Randy J and Yao, Qiyuan and Xu, Bo and Shao, Yikai},
title = {Targeting hepcidin to restore oral iron efficacy after vertical sleeve gastrectomy},
journal = {Frontiers in Nutrition},
year = {2026},
volume = {13},
doi = {10.3389/fnut.2026.1746572}
}
EUVIMED